Below are some of the top analyst calls we are seeing from Wall Street firms this Thursday morning:
Biogen Idec (BIIB) Raised to Buy at Lazard.
Cowen (COWN) Raised to Outperform at KBW.
Mylan Labs (MYL) Started as Strong Buy at Needham.
Par Pharmaceuticals (PRX) Started as Strong Buy at Needham.
Smart Balance (SMBL) Started as Buy at Lazrd.
Teva Pharma (TEVA) Started as Strong Buy at Needham.
Cadbury Schwepps (CBY) Cut to Sell at Citigroup.
Carnival (CCL) Cut to Sell at Deutsche Bank.
Dolby Labs (DLB) Cut to Hold at Deutsche Bank.
JCPenney (JCP) Cut to Underperform at Merrill Lynch.
Jefferies (JEF) Cut to Underperform at KBW.
Prosperity Bancshares (PRSP) Cut to Market Perform at KBW.
Jon C. Ogg September 25, 2008
Smart Investors Are Quietly Loading Up on These “Dividend Legends”
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats.
There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside.
If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.